Metrics to compare | MSMP | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMSMPPeersSector | |
|---|---|---|---|---|
P/E Ratio | 20.5x | −10.4x | −0.3x | |
PEG Ratio | - | 0.09 | 0.00 | |
Price/Book | 2.2x | 1.9x | 2.6x | |
Price / LTM Sales | 0.4x | 0.9x | 3.0x | |
Upside (Analyst Target) | - | 24.8% | 56.6% | |
Fair Value Upside | Unlock | 8.1% | 10.2% | Unlock |
Massmedica S.A. engages in the distribution of implants and other medical materials used in the treatment of musculoskeletal system diseases, aesthetic and regenerative medicines in Poland. It provides products in the field of reconstructive, regenerative, anti-aging, and aesthetic medicine. The company’s products include supplements, skin care, sun protection, creams, tools, serum, masks, carboxytheraphy, and intra-articular injections. It also offers reconstructive products, such as hip endoprostheses, 3D endoportesis, and synthetic tendon ligaments; HA based tissue fillers (Cytosial), kits for collecting and preparing adipose tissue for autologous transplantation; and Endor, is a dermocosmetics based on a patented gold molecule combined with short chains of HA with properties that strongly induce the production of endogenous collagen, elastin and hyaluronic acid. The company offers its products to public and private hospitals. Massmedica S.A. was founded in 2011 and is headquartered in Warsaw, Poland.